Orchid Pharma Ltd
NSE:ORCHPHARMA
Orchid Pharma Ltd
NSE:ORCHPHARMA
Price:
800
INR
2.95%
Market Cap:
40.6B
INR
P/E
Price to Earnings
Price to Earnings
33.9
Current
34.5
Median
20.5
Industry
Lower
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=33.9
Market Cap
/
40.6B INR
Net Income
1.2B INR
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
45
2-Years Forward
P/E
26.6
3-Years Forward
P/E
13
You don't have any saved screeners yet
